Allergic asthma is the most common type, affecting around 60% of people with asthma. Both allergic and non-allergic asthma have the same symptoms, such as shortness of breath and wheezing. 

The human body is host to trillions of microbes, or bacteria. Some of these are useful, and some are harmful. The human microbiota consists of a wide variety of bacteria, viruses, fungi, and other single-celled animals that live in the body. Every human being harbors anywhere between 10 trillion and 100 trillion microbial cells in a symbiotic relationship. This benefits both the microbes and their hosts, as long as the body is in a healthy state. Estimates vary, but there could be over 1,000 different species of microorganism making up the human microbiota. 

The biggest populations of microbes reside in the gut. Recent applications of culture-independent tools for microbiome profiling have revealed significant relationships between asthma and microbiota associated with the environment, gut or airways. Studies of the airway microbiome in particular represent a new frontier in pulmonary research. 

Allergic rhinitis (AR) and allergic asthma are caused by an IgE-mediated inflammatory reaction. Probiotics may exert anti-inflammatory and immune-modulatory activity.  A Study using a probiotic mixture of Bifidobacterium longum BB536 and Bifidobacterium breve M-16V showed that Children treated with probiotic mixture achieved a significant improvement of symptoms (p < 0.005), and QoL ((p < 0.001). Placebo group had worsening of symptoms (p < 0.005) and QoL (p < 0.001).  [Ref: Ital J Pediatr. 2017 Mar 7;43(1):25. doi: 10.1186/s13052-017-0340-5.] 

Scientists found that those who consumed the least amount of soy had the most flare-ups of their asthma symptoms. Research also has shown that soy isoflavones can slow the production of inflammatory components in the bloodstream. Inflammation is an important cause of asthma symptoms. [https://source.wustl.edu/2010/08/could-soy-reduce-asthma-symptoms/]                                                                                                                                                         

AFA (Aphanizomenon-flos aquae) cyanobacteria are unicellular algae with potent leukotriene B4 inhibitory properties that act as leukotriene modifiers that help manage mild to moderate to severe asthma. Studies have shown that leukotriene influx causes allergic bronchoconstriction followed by asthma attacks.

EnerFlex ECZYBIO and EnerFlex AFA750 provide the essential and functional nutrients that may help improve the quality of life of both allergic asthma and non-allergic asthma. One thing for sure is that the founder/inventor of EnerFlex with a suffering of 26 years of allergic asthma was fully cured by EnerFlex without using any anti-asthmatic medications since 5 December 2000 until to-date.

Package Supply contains 2 boxes of EnerFlex AFA750 and 2 boxes of EnerFlex  ECZYBIO

Direction of Use:  Dissolve a mixed beverage containing 1 sachet of EnerFlex AFA750 and 1 sachet of EnerFlex ECZYBIO in 180 - 200ml of luke warm water. Drink immediately. 

Take an additional 2 sachets of EnerFlex AFA750 in the afternoon around 3 - 5 pm for one to two weeks.